Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
종목 코드 SLGL
회사 이름Sol Gel Technologies Ltd
상장일Feb 01, 2018
CEO- -
직원 수34
유형Ordinary Share
회계 연도 종료Feb 01
주소Golda Meir 7
도시NESS-ZIONA
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호- -
전화97289313433
웹사이트http://www.sol-gel.com
종목 코드 SLGL
상장일Feb 01, 2018
CEO- -
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음